Skip to main content

Table 2 The outcome comparison between the DHEA FF group versus the control FF group

From: Dehydroepiandrosterone improves follicular fluid bone morphogenetic protein-15 and accumulated embryo score of infertility patients with diminished ovarian reserve undergoing in vitro fertilization: a randomized controlled trial

Paremeters

The DHEA FF group

The control FF group

P-value

 

n = 26

n = 35

 

Age (years)

36.58 ± 5.95

37.83 ± 4.28

.367

BMI (kg/m2)

22.49 ± 3.10

22.66 ± 2.39

.813

Duration of infertility(years)

7.04 ± 4.99

6.60 ± 5.01

.736

Primary infertility (%)

42.31%

25.71%

.270

Secondary infertility (%)

57.69%

74.29%

 

AMH (ng/ml)

1.00 ± 0.81

1.19 ± 0.94

.496

FSH (mIU/mL)

11.78 ± 4.92

10.70 ± 2.40

.406

Estradiol (pg/ml)

174.47 ± 122.85

190.45 ± 145.87

.653

Antral follicle count

3.73 ± 1.04

3.51 ± 1.29

.486

BMP-15 (ng/ml)

0.81 ± 0.25

0.35 ± 0.23

.000

GDF-9 (ng/ml)

7.91 ± 3.77

6.82 ± 2.46

.203

  1. Data are presented as mean ± SD (standard deviation) or percentage as appropriate. FF: Follicular fluid. P<.05 was considered as statistically significant.